Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Stockholm - Delayed Quote • SEK Sedana Medical AB (publ) (SEDANA.ST) Follow Add holdings 10.34 +0.24 +(2.38%) At close: April 25 at 5:29:49 PM GMT+2 All News Press Releases SEC Filings Sedana Medical AB (STU:7D2A) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... Sedana Medical AB (STU:7D2A) reports a 17% annual revenue growth, strategic acquisitions, and positive trial results, despite challenges in key markets. Sedana Medical AB (FRA:7D2A) Q3 2024 Earnings Call Highlights: Record Sales and Strategic Moves ... Despite challenges, Sedana Medical AB (FRA:7D2A) reports its highest Q3 net sales and raises full-year sales guidance, driven by strong market performance and strategic acquisitions. Sedana Medical completes patient recruitment for its clinical program in the US Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 2 phase III clinical trial in the United States. Earlier this spring, Sedana Medical reported the completion of enrolment to the parallel phase III clinical trial INSPiRE-ICU 1. The company anticipates topline results from both trials in the second half of 2024, with a planned New Drug Application (NDA) submission in the first quarter of 2025. Performance Overview Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) Return SEDANA.ST OMX Stockholm 30 Index (^OMX) YTD -45.81% -2.26% 1-Year -45.35% -3.90% 3-Year -79.86% +18.35%